Holen Sie sich die Stockscreener-App
4.58
5.95%
-0.29
Vorhandelsmarkt:
4.45
-0.13
-2.84%
Schlusskurs vom Vortag:
$4.87
Offen:
$4.9
24-Stunden-Volumen:
48,414
Relative Volume:
0.49
Marktkapitalisierung:
$17.60M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-25.89%
1M Leistung:
-37.52%
6M Leistung:
-59.67%
1J Leistung:
+203.31%
1-Tages-Spanne:
$4.50
$4.9828
1-Wochen-Bereich:
$4.50
$6.18
52-Wochen-Spanne:
$1.48
$19.12
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Firmenname
Quantum Biopharma Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie QNTM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
4.58 | 18.72M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.90 | 120.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.45 | 78.77B | 14.34B | 4.50B | 3.88B | 41.57 |
|
ARGX
Argen X Se Adr
|
840.50 | 52.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
338.06 | 45.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
340.38 | 38.73B | 4.98B | 69.60M | 525.67M | 0.5198 |
Quantum Biopharma Ltd Aktie (QNTM) Neueste Nachrichten
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma - GlobeNewswire
CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming DeadlinesQNTM - Prime Publishers, Inc.
Targets Report: Will Quantum BioPharma Ltd stock benefit from M A2025 Bull vs Bear & Free Community Consensus Stock Picks - baoquankhu1.vn
Will Quantum BioPharma Ltd stock benefit from M AMarket Trend Report & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares - Corning Leader
Quantum Biopharma Shareholders File Class Action Lawsuit - Intellectia AI
CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM - GlobeNewswire Inc.
Quantum Biopharma Ltd. Class Action Alert for Investors - Intellectia AI
Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma Ltd. Investors - GlobeNewswire
Quantum Biopharma Reports Q3 2025 Financial Results - MSN
Risk Recap: Will QNTM stock go up in YEARJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - baoquankhu1.vn
QNTM Shareholders Have Opportunity to Lead Quantum Biopharma Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
QNTM Investors Have Opportunity to Lead Quantum Biopharma Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
QNTM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Quantum Biopharma Ltd. Faces Class Action Lawsuit Over Alleged Securities Fraud - Intellectia AI
User - FinancialContent
Why Quantum BioPharma Ltd. (0K91) stock signals breakout potentialWeekly Stock Analysis & Weekly Watchlist for Hot Stocks - bollywoodhelpline.com
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Aug Mood: Should I hold or sell Quantum BioPharma Ltd now - baoquankhu1.vn
QNTM STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Quantum Biopharma Ltd. to Contact the Firm Today! - ACCESS Newswire
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Quantum Biopharma Ltd. to Contact the Firm Today! - ACCESS Newswire
Aug Outlook: Will Quantum BioPharma Ltd. outperform during market ralliesVolume Spike & Low Volatility Stock Recommendations - baoquankhu1.vn
CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM - Chartmill
Whittier Daily News - FinancialContent
Buyback Watch: Will Quantum BioPharma Ltd. stock attract ESG investors2025 Growth vs Value & Fast Entry and Exit Trade Plans - Bộ Nội Vụ
QNTM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
QNTM DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Quantum Biopharma Ltd. (QNTM) and Lead Plaintiff Deadline on February 23, 2026 - NewMediaWire
Spoofing Allegations Against Banks Take Center Stage in Biotech’s Legal Fight - InvestorNews
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
About Us - FinancialContent
QUANTUM BIOPHARMA DEADLINE FOR LEADERSHIP is February 23, 2026 in - The National Law Review
Quantum BioPharma closes private placement, enhances governance - MSN
QUANTUM BIOPHARMA DEADLINE FOR LEADERSHIP is February 23, 2026 in a Securities Fraud LawsuitContact Kaplan Fox & Kilsheimer LLP - NewMediaWire
Daily Breeze - FinancialContent
Quantum BioPharma Heads For Best Week Ever — But Most Retail Traders Lament Missing Out On The Surge - MSN
Deadline to Lead in Securities Class Action Against Quantum Biopharma Ltd. (QNTM) is February 23, 2026Contact Kaplan Fox - NewMediaWire
Deadline to Lead in Securities Class Action Against Quantum Bioph - The National Law Review
QNTM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
How supply chain issues affect Quantum BioPharma Ltd. stockJuly 2025 Big Picture & AI Forecasted Stock Moves - Улправда
Will Quantum BioPharma Ltd. stock attract ESG investorsJuly 2025 Momentum & Stepwise Trade Signal Guides - Улправда
How strong is Quantum BioPharma Ltd. stock balance sheetTreasury Yields & Real-Time Volume Trigger Notifications - Улправда
Will Quantum BioPharma Ltd. (0K91) stock enhance shareholder value2025 Price Momentum & Free Expert Verified Stock Movement Alerts - Улправда
QNTM CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Quantum Biopharma Ltd. (QNTM) and Lead Plaintiff Deadline on February 23, 2026 - NewMediaWire
Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Quantum Biopharma Ltd. (QNTM) and Lead Plaintiff Deadline on February 23, 2026 - FinancialContent
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
How Quantum BioPharma Ltd. stock reacts to global recession fearsRetail Trading Trends & Budget Friendly Trading Ideas - Улправда
Is Quantum BioPharma Ltd. (0K91) stock dividend growth reliableStock Watchlist Updates & Big Returns Small Capital - ulpravda.ru
QNTM DEADLINE: Investors of Quantum Biopharma Ltd. (QNTM) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on February 23, 2026 - NewMediaWire
Kaplan Fox Alerts Quantum Biopharma Ltd. (QNTM) Investors to a Se - The National Law Review
Finanzdaten der Quantum Biopharma Ltd-Aktie (QNTM)
Es liegen keine Finanzdaten für Quantum Biopharma Ltd (QNTM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):